XML 50 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Mar. 31, 2010
Dec. 31, 2017
Dec. 31, 2016
Fair Value Measurement [Line Items]      
Cumulative Liability   $ 17,500,000 $ 16,700,000
Manhattan and Ariston Pharmaceuticals Merger [Member]      
Fair Value Measurement [Line Items]      
Notes Issued $ 15,500,000    
Debt Instrument, Convertible, Conversion Price $ 1,125    
Percentage Of Cash Proceeds From Operation To Repay Convertible Debt 50.00%    
Debt Instrument, Term 5 years    
Debt Instrument, Interest Rate During Period 5.00%    
Convertible Notes Payable [Member]      
Fair Value Measurement [Line Items]      
Cumulative Liability   $ 17,500,000 $ 16,700,000
Debt Instrument, Convertible, Conversion Price   $ 1,125 $ 1,125
Debt Instrument, Interest Rate During Period   5.00%